[The treatment of solid tumors with monoclonal antibodies].
Patients with B-cell lymphomas, gastrointestinal tumors and melanomas were treated in pilot and phase-I clinical studies with monoclonal antibodies directed to tumor-associated antigens in recent years. Side effects of this new treatment approach were minor. Tumor regressions were observed in all three groups of tumors.
Dippold
W G
WG
I. Medizinische Klinik und Poliklinik, Universität Mainz.
Meyer zum Büschenfelde
K H
KH
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005770:Gastrointestinal Neoplasms / Q000628:therapy*; D006801:Humans; D008223:Lymphoma / Q000628:therapy*; D008545:Melanoma / Q000628:therapy*
D000911:Antibodies, Monoclonal
Behandlung solider Tumoren mit monoklonalen Antikörpern.